封面
市場調查報告書
商品編碼
1984150

生物防治劑市場:2026-2032年全球市場預測(依產品類型、作物類型、製劑形式、應用方法、通路和最終用戶分類)

Biological Control Agents Market by Product Type, Crop Type, Formulation, Mode Of Application, Distribution Channel, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,生物害蟲防治市場價值將達到 61.2 億美元,到 2026 年將成長至 65.9 億美元,年複合成長率為 7.74%,到 2032 年將達到 103.2 億美元。

主要市場統計數據
基準年 2025 61.2億美元
預計年份:2026年 65.9億美元
預測年份 2032 103.2億美元
複合年成長率 (%) 7.74%

為引入生物防治提供了一個背景框架,闡明了影響整個作物保護組合策略決策的監管、農業化學品和商業性促進因素。

隨著相關人員尋求永續的、生物防治的替代傳統化學防治方法,農業格局正在經歷根本性的變革。對合成農藥日益嚴格的監管、消費者對無殘留農產品的需求不斷成長,以及對具有韌性的供應鏈日益迫切的需求,共同推動了生物防治從一項小眾創新發展成為一項戰略重點。本文闡述了生物防治(包括資訊素、植物萃取物、活體大型生物和微生物製劑)如何融入更廣泛的作物保護方案,以及它如何影響長期的農業化學品策略。

科學進步、監管改進和不斷發展的商業管道如何改變生物害蟲防治的引入途徑和競爭動態。

生物防治劑領域的格局正因科學、監管和商業策略的融合變革而重塑,這些變革共同改變了競爭動態和推廣途徑。微生物基因組學、精準製劑和遞送技術的進步提高了生物防治劑的一致性和靶向性,從而縮小了生物防治劑與傳統化學農藥之間的認知差距。此外,昆蟲學家、微生物學家和製劑科學家之間的跨學科合作正在開發出結合互補作用機制並簡化施用物流的綜合產品。

本分析探討了近期關稅變化如何重塑生物防治利害關係人的採購經濟、供應鏈韌性和策略製造決策。

近期實施的關稅措施和貿易政策調整(預計在2025年前後生效)正對全球農業投入價值鏈產生累積壓力,尤其對生物防治產品造成衝擊,因為其價值依賴於專用原料、精密製造程序和跨境分銷。某些農產品和成品關稅的提高推高了依賴海外供應鏈產品的接收成本,促使製造商重新評估籌資策略並評估其龐大供應商網路的韌性。在某些情況下,關稅帶來的成本壓力正在加速企業將生產轉移回國內和區域化,以降低貿易波動帶來的風險。

將產品類型、作物應用、配方、應用方法、最終用戶畫像和分銷管道與商業化策略聯繫起來的綜合細分分析。

精細化的市場細分觀點對於使產品開發和市場進入策略與終端用戶在不同作物、配方和應用方法方面的需求相匹配至關重要。產品類型細分包括生物化學品(如資訊素和植物萃取物)、大型生物(如線蟲、寄生性天敵和捕食性昆蟲)以及微生物製劑(由細菌、真菌和病毒組成),每種產品都有其獨特的功效、儲存要求和監管要求。作物類型細分涵蓋穀物、水果和蔬菜、油籽和豆類以及草坪和觀賞植物,普通作物和特種作物在病蟲害危害、收穫時間和殘留限量方面存在顯著差異。

美洲、歐洲、中東和非洲以及亞太地區的區域差異和營運要求影響實施、監管策略和分銷模式。

區域趨勢對生物防治的研發、引進和商業化具有決定性影響,每個地理叢集都有其獨特的管理體制、氣候條件和分銷基礎設施。在美洲,多樣化的生產體系和零售商先進的永續性措施為生物防治解決方案創造了有利環境,但國家和地方政府層面的複雜法規要求採取個人化的註冊和合規方法。在歐洲、中東和非洲,法律規範往往側重於環境安全和可追溯性,市場准入通常取決於是否符合嚴格的田間試驗數據和認證體系,而全部區域氣候和物流的多樣性則要求對產品進行區域性調整。

生物防治生態系中創新者、產品組合擴展公司和區域製造商之間的競爭定位和能力建構優先事項。

生物防治領域的競爭動態由三類企業共同塑造:高度專業化的創新企業、不斷拓展產品線的成熟農資企業以及專注於本地生產的區域性製造商。主要企業強調嚴格的田間檢驗、可擴展的生產流程以及將產品供應與技術諮詢支援相結合的綜合服務。投資重點集中在配方科學(以提高穩定性)、精準噴灑技術(以提高防治效果)以及品質保證系統(以確保批次間一致性)。

為領導者提供的實用策略指南,重點在於現場檢驗、配方創新、本地生產和綜合服務模式,以加速推廣應用。

產業領導企業應採取協作策略,平衡短期商業化與長期能力建設,以實現價值最大化並加速產品推廣應用。首先,投資穩健的田間檢驗項目,以在不同的農業生態區域和種植系統中產生可重複的功效數據。優先考慮的證據能夠減少推廣應用的障礙,並有助於獲得監管部門的核准。其次,開發配方和應用方法的創新,以延長產品保存期限並提高易用性,從而減少經銷商和生產商面臨的物流限制。第三,推廣本地化生產或策略性合約生產,以降低貿易風險並縮短生技藥品供應鏈的時間限制。

調查方法結合了對專家的直接訪談、同行評審的證據、監管文件審查和供應鏈分析,以得出可操作的策略見解。

本研究結合對技術專家、供應鏈負責人和政策顧問的訪談,以及對同行評審文獻、已發布的監管文件和原始田間試驗總結的系統性回顧,建構了生物防治技術應用趨勢的全面觀點。研究還從多個種植系統和地區的實踐者收集了定性數據,以反映實際應用和限制。這些研究結果與實驗室和田間功效報告進行了交叉比對,以確保觀察結果與報告指標的一致性。

整合科學進步、監管趨勢和商業性需求,為生物防治解決方案的永續擴展制定切實可行的路徑。

科學、監管和商業性證據的整合表明,生物防治劑已不再是邊緣選項,而是韌性作物保護策略的核心組成部分,這標誌著一個轉折點的到來。技術進步和配方改進正在縮小性能差距,新的法規和商業模式正在降低推廣應用的門檻。同時,關稅趨勢和供應鏈風險凸顯了生產柔軟性和區域生產能力對於維持供應連續性的重要性。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章:生物防治劑市場:依產品類型分類

  • 生化物質
    • 資訊素
    • 植物萃取物
  • 大型生物
    • 線蟲
    • 寄生天敵
    • 捕食性昆蟲
  • 微生物製劑
    • 細菌
    • 真菌
    • 病毒

第9章:生物防治劑市場:依作物類型分類

  • 糧食
  • 水果和蔬菜
  • 油籽和豆類
  • 草坪和觀賞植物

第10章:以劑型分類的生物防治劑市場

  • 顆粒
  • 液體
  • 可濕性粉

第11章:以施用方法分類的生物防治劑市場

  • 葉面噴布
  • 後處理
  • 種子處理
  • 土壤處理

第12章:生物防治市場:依通路分類

  • 直銷
  • 批發商和零售商
  • 線上管道

第13章:生物害蟲防治市場:依最終用戶分類

  • 商業農業
  • 溫室
  • 家居與園藝
  • 園藝

第14章:生物防治市場:依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章:生物防治劑市場:依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章:生物防治劑市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章:美國生物醫學控制市場

第18章:中國生物防治市場

第19章 競爭情勢

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Anatis Bioprotection Ltd.
  • Andermatt Biocontrol AG
  • Arbico Organics, Inc.
  • BASF SE
  • Bayer AG
  • BioBee Sde Eliyahu Ltd.
  • Biobest Group NV
  • Bioceres Crop Solutions Corp.
  • BioFirst Group, Inc.
  • Bioline AgroSciences Ltd.
  • BioWorks, Inc.
  • CBC
  • Certis Biologicals BV
  • FMC Corporation
  • Isagro SpA
  • Koppert Biological Systems BV
  • Marrone Bio Innovations, Inc.
  • Natural Insect Control, Inc.
  • Novozymes A/S
  • Nufarm Limited
  • Sumitomo Chemical Co., Ltd.
  • Syngenta Group AG
  • UPL Corporation Limited
  • Valent BioSciences LLC
Product Code: MRR-5C6F41F5AF8C

The Biological Control Agents Market was valued at USD 6.12 billion in 2025 and is projected to grow to USD 6.59 billion in 2026, with a CAGR of 7.74%, reaching USD 10.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.12 billion
Estimated Year [2026] USD 6.59 billion
Forecast Year [2032] USD 10.32 billion
CAGR (%) 7.74%

Contextual framing of biological control adoption that clarifies regulatory, agronomic, and commercial drivers shaping strategic decisions across crop protection portfolios

The agricultural landscape is undergoing a foundational shift as stakeholders seek sustainable, biologically based alternatives to conventional chemical controls. Increasing regulatory scrutiny on synthetic pesticides, heightened consumer demand for residue-free produce, and the intensifying need for resilient supply chains have converged to elevate biological control agents from niche innovation to strategic priority. This introduction establishes the context for understanding how biologicals-ranging from pheromones and plant extracts to living macroorganisms and microbial agents-fit into broader crop protection portfolios and influence long-term agronomic strategies.

Adoption is being driven by practical imperatives as much as by values. Growers face mounting pressure to reduce input risk, meet retailer specifications, and conform to evolving certification standards. In response, product developers and distributors are refining formulations, application modes, and delivery systems to enhance consistency, shelf life, and field performance. Simultaneously, investment in R&D and localized manufacturing is accelerating to address variability across climates and cropping systems. The net effect is a maturing ecosystem where biology-led tools are increasingly integrated into integrated pest management plans rather than being positioned as last-resort options.

This framing sets the stage for deeper analysis of technological breakthroughs, regulatory developments, and commercial dynamics that together shape the trajectory of biological control adoption. Understanding these drivers and constraints is essential for executives and technical leaders formulating strategies to scale efficacy, manage risk, and capture value from next-generation crop protection solutions.

How scientific advances, regulatory refinement, and evolving commercial channels are converging to transform adoption pathways and competitive dynamics in biological control

The landscape for biological control agents is being reshaped by convergent shifts in science, regulation, and commercial strategy that collectively alter competitive dynamics and adoption pathways. Advances in microbial genomics, precision formulation, and delivery technologies are improving consistency and targeting, which in turn reduces the perception gap between biologicals and conventional chemistries. Moreover, cross-disciplinary collaborations between entomologists, microbiologists, and formulation scientists are producing integrated products that combine complementary modes of action while streamlining application logistics.

On the regulatory front, agencies are refining pathways to evaluate efficacy and environmental safety, and private standards are raising the bar for residue and sustainability credentials. These developments favor suppliers who can demonstrate robust field data and transparent production practices. In parallel, commercial channels are evolving: digital agronomy platforms and data-driven advisory services are enabling targeted recommendations, while upstream supply chain actors are investing in storage and cold-chain solutions to maintain viability of living products. As a result, market participants are shifting from transactional sales models toward partnership-based engagement that emphasizes on-farm performance and lifecycle support.

Together, these transformative shifts are lowering technical and commercial barriers to adoption, accelerating integration of biological control agents into mainstream crop protection strategies, and prompting incumbents and new entrants alike to reorient their R&D and go-to-market approaches toward resilience, traceability, and demonstrable field outcomes.

Analyzing how recent tariff shifts have reshaped sourcing economics, supply chain resilience, and strategic manufacturing decisions for biological control stakeholders

Recent tariff actions and trade policy shifts introduced in and around 2025 have exerted cumulative pressure across global agricultural input supply chains, with particular implications for biological control agents whose value depends on specialized raw materials, manufacturing precision, and cross-border distribution. Increased duties on certain inputs and finished goods have raised landed costs for products that rely on immigrant supply chains, prompting manufacturers to reassess sourcing strategies and to evaluate the resilience of extended supplier networks. In some cases, tariff-induced cost pressure has accelerated onshoring initiatives and closer regionalization of production to reduce exposure to trade volatility.

These trade measures have also affected the logistics and inventory calculus for distributors and growers. Higher import costs combined with uncertainty over tariff permanence have encouraged larger safety stocks of viable biological products and greater demand for domestically produced alternatives. At the same time, supply chain participants have faced higher working capital requirements and greater complexity in compliance, including additional documentation and customs processes that can impact shelf life-sensitive agents. Consequently, companies with vertically integrated capabilities or diversified sourcing options have found it easier to absorb or mitigate tariff-related disruptions.

Importantly, tariff dynamics have prompted strategic re-evaluation rather than universal contraction. Many firms have accelerated investments in local manufacturing scale-up, technology transfer partnerships, and licensing agreements to preserve market access and control cost trajectories. Policymakers, procurement teams, and industry leaders must now balance short-term cost impacts against longer-term benefits of supply chain resilience, nearshoring, and strategic inventory management to maintain continuity of biological control deployment across diverse cropping systems.

Integrated segmentation analysis that links product types, crop applications, formulations, application modes, end-user profiles, and distribution channels to commercialization strategy

A nuanced segmentation perspective is essential to align product development and go-to-market strategies with end-user needs across crops, formulations, and application modes. Product type differentiation encompasses biochemicals such as pheromones and plant extracts, macroorganisms including nematodes, parasitoids, and predatory insects, and microbial agents comprising bacteria, fungi, and viruses, each with distinct efficacy profiles, storage requirements, and regulatory considerations. Crop type segmentation spans cereals and grains, fruits and vegetables, oilseeds and pulses, and turf and ornamentals, with pest pressure, harvest windows, and tolerance for residue varying substantially between commodity and specialty crops.

Formulation choices-granules, liquid, and wettable powders-drive logistics, shelf life, and ease of integration into existing spray or soil treatment systems, while modes of application such as foliar application, post-harvest application, seed treatment, and soil treatment determine compatibility with farm equipment and labor practices. End-user categories range from commercial agriculture and greenhouses to home and garden and horticulture, each demanding different service models, technical support, and packaging sizes. Distribution channels including direct sales, distributors and retailers, and online channels influence margin structures, after-sales service expectations, and adoption velocity.

Taken together, these segmentation dimensions inform product roadmaps, regulatory strategies, and channel investments. A coordinated approach that maps product attributes to crop-specific pest challenges and end-user operational realities increases the probability of successful commercialization and long-term uptake.

Regional differentiation and operational imperatives that shape adoption, regulatory strategy, and distribution models across the Americas, Europe Middle East Africa, and Asia Pacific

Regional dynamics exert a defining influence on biological control development, adoption, and commercialization, with each geographic cluster presenting distinct regulatory regimes, climatic conditions, and distribution infrastructures. In the Americas, diverse production systems and progressive sustainability commitments among retailers have created fertile ground for biological solutions, though regulatory complexity across national and subnational jurisdictions requires tailored registration and compliance approaches. In Europe, Middle East & Africa, regulatory frameworks tend to emphasize environmental safety and traceability, and market access often depends on rigorous field trial data and alignment with certification schemes, while climatic and logistical heterogeneity across the region necessitate region-specific product adaptations.

The Asia-Pacific region is characterized by rapidly modernizing agricultural systems, intense pest pressures in many subtropical cropping zones, and growing demand for reduced-residue practices. Here, the speed of adoption is influenced by farmer economics, distribution density, and the availability of local technical advisory services. Across all regions, the capacity to maintain product viability through cold-chain and storage solutions, to provide on-the-ground technical support, and to navigate local regulatory pathways is a decisive factor. Regional partnerships, contract manufacturing arrangements, and targeted field demonstration programs often prove more effective than one-size-fits-all commercial models.

Understanding these regional nuances enables companies to prioritize investments, structure regulatory dossiers, and design deployment strategies that respect local agronomic realities while leveraging global science and supply capabilities to scale impact.

Competitive positioning and capability-building priorities that distinguish innovators, portfolio expanders, and regional manufacturers in the biological control ecosystem

Competitive dynamics in the biological control space are shaped by a mix of specialized innovators, agri-input incumbents expanding their portfolios, and regional manufacturers focused on localized production. Leading firms emphasize rigorous field validation, scalable production processes, and integrated service offerings that combine product supply with technical advisory support. Investment priorities are concentrated on formulation science to improve stability, precision application technology to enhance efficacy, and quality assurance systems to ensure consistency across batches.

Strategic partnerships, licensing arrangements, and acquisitions are common as companies seek to close capability gaps, access new crops or geographies, and accelerate time-to-market for promising candidates. Equally important is the development of distribution networks that can handle biologically sensitive goods, including cold-chain logistics and specialized retailer education. Firms that succeed typically integrate a strong R&D backbone with market-facing teams capable of translating trial data into practical agronomic recommendations and commercial programs tuned to local grower needs.

Intellectual property, regulatory dossiers, and validated field protocols represent competitive moats that support premium positioning. At the same time, collaborative research consortia and public-private partnerships are expanding the evidence base for biological controls, enabling broader acceptance and faster integration into integrated pest management systems. For commercial leaders, the path forward combines scientific rigor, operational excellence, and customer-centric service models.

Actionable strategic playbook for leaders centered on field validation, formulation innovation, regional production, and integrated service models to accelerate adoption

Industry leaders should pursue a coordinated strategy that balances near-term commercialization with long-term capability building to capture value and accelerate adoption. First, invest in robust field validation programs that generate reproducible efficacy data across diverse agroecological zones and cropping systems; prioritized evidence reduces adoption friction and supports regulatory acceptance. Second, develop formulation and delivery innovations to improve product shelf life and ease of use, thereby reducing logistical constraints for distributors and growers. Third, pursue regional manufacturing or strategic contract production to mitigate trade-related exposure and to shorten supply chains for time-sensitive biologicals.

In parallel, cultivate integrated service models that combine product supply with digital advisory tools, extension services, and training programs to maximize on-farm performance. Forge strategic partnerships with input distributors, research institutions, and local agronomy networks to accelerate market penetration in priority geographies. Additionally, align regulatory engagement with transparent quality controls and environmental safety data to streamline registration pathways and to reassure procurement stakeholders. Finally, adopt flexible commercial terms and packaging options to address the distinct needs of commercial agriculture, greenhouse operations, and home gardeners, while investing in education that demonstrates return-on-practice rather than relying solely on product claims.

By implementing these actions, companies can reduce adoption barriers, strengthen stakeholder trust, and create scalable pathways for biological control agents to complement and, where appropriate, replace conventional interventions.

Methodological approach combining primary expert interviews, peer-reviewed evidence, regulatory dossier reviews, and supply chain analysis to derive practical strategic insights

This research synthesizes primary interviews with technical experts, supply chain leaders, and policy advisors together with a structured review of peer-reviewed literature, public regulatory filings, and proprietary field trial summaries to build a comprehensive perspective on biological control adoption dynamics. Primary qualitative inputs were collected from practitioners across multiple crop systems and geographies to capture operational realities and adoption constraints. These insights were triangulated with laboratory and field efficacy reports to ensure coherence between observed outcomes and reported metrics.

Analytical methods emphasized comparative evaluation across product types, formulation classes, and application modes, while paying particular attention to regional regulatory pathways and distribution capabilities. Supply chain analyses incorporated logistics constraints, manufacturing lead-times, and sensitivity to trade policy shifts. Where available, longitudinal field trial data were reviewed to assess repeatability and robustness under varying climatic and agronomic conditions. The methodology prioritizes transparency in data provenance, replicability in comparative assessments, and practical relevance for decision-makers responsible for R&D prioritization, regulatory planning, and commercialization strategy.

Limitations of the methodology include variability in publicly available field data and differences in trial design across regions; therefore, conclusions emphasize patterns and strategic implications rather than single-study extrapolations. The approach nonetheless provides a defensible foundation for executives to inform investment choices and operational planning.

Synthesis of scientific advancements, regulatory trends, and commercial imperatives that define a pragmatic route for scaling biological control solutions sustainably

The synthesis of scientific, regulatory, and commercial evidence points to an inflection where biological control agents become central components of resilient crop protection strategies rather than peripheral options. Technological advancements and formulation improvements have narrowed performance gaps, while new regulatory and commercial models are reducing barriers to deployment. At the same time, tariff dynamics and supply chain risks underscore the importance of manufacturing flexibility and regional production capabilities to preserve continuity of supply.

Strategic success will hinge on the ability of companies to connect rigorous efficacy data with operationalized delivery systems and to provide service models that translate product attributes into reliable on-farm outcomes. Collaboration across stakeholders-suppliers, distributors, researchers, and policymakers-will be key to harmonizing standards, accelerating registration processes, and building grower confidence. In short, biological control agents present a pragmatic pathway to more sustainable pest management, but their widescale impact depends on coordinated investment in science, logistics, and market development.

Executives and technical leaders should therefore prioritize integrated strategies that address evidence generation, regulatory alignment, and supply chain resilience, enabling biological solutions to scale in ways that are economically viable, environmentally responsible, and operationally practical.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Control Agents Market, by Product Type

  • 8.1. Biochemicals
    • 8.1.1. Pheromones
    • 8.1.2. Plant Extracts
  • 8.2. Macroorganisms
    • 8.2.1. Nematodes
    • 8.2.2. Parasitoids
    • 8.2.3. Predatory Insects
  • 8.3. Microbial Agents
    • 8.3.1. Bacteria
    • 8.3.2. Fungi
    • 8.3.3. Viruses

9. Biological Control Agents Market, by Crop Type

  • 9.1. Cereals And Grains
  • 9.2. Fruits And Vegetables
  • 9.3. Oilseeds And Pulses
  • 9.4. Turf And Ornamentals

10. Biological Control Agents Market, by Formulation

  • 10.1. Granules
  • 10.2. Liquid
  • 10.3. Wettable Powders

11. Biological Control Agents Market, by Mode Of Application

  • 11.1. Foliar Application
  • 11.2. Post-Harvest Application
  • 11.3. Seed Treatment
  • 11.4. Soil Treatment

12. Biological Control Agents Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors And Retailers
  • 12.3. Online Channels

13. Biological Control Agents Market, by End User

  • 13.1. Commercial Agriculture
  • 13.2. Greenhouses
  • 13.3. Home And Garden
  • 13.4. Horticulture

14. Biological Control Agents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Biological Control Agents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Biological Control Agents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Biological Control Agents Market

18. China Biological Control Agents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Anatis Bioprotection Ltd.
  • 19.6. Andermatt Biocontrol AG
  • 19.7. Arbico Organics, Inc.
  • 19.8. BASF SE
  • 19.9. Bayer AG
  • 19.10. BioBee Sde Eliyahu Ltd.
  • 19.11. Biobest Group N.V.
  • 19.12. Bioceres Crop Solutions Corp.
  • 19.13. BioFirst Group, Inc.
  • 19.14. Bioline AgroSciences Ltd.
  • 19.15. BioWorks, Inc.
  • 19.16. CBC
  • 19.17. Certis Biologicals B.V.
  • 19.18. FMC Corporation
  • 19.19. Isagro S.p.A.
  • 19.20. Koppert Biological Systems B.V.
  • 19.21. Marrone Bio Innovations, Inc.
  • 19.22. Natural Insect Control, Inc.
  • 19.23. Novozymes A/S
  • 19.24. Nufarm Limited
  • 19.25. Sumitomo Chemical Co., Ltd.
  • 19.26. Syngenta Group AG
  • 19.27. UPL Corporation Limited
  • 19.28. Valent BioSciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PHEROMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PHEROMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PHEROMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PLANT EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PLANT EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY NEMATODES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY NEMATODES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY NEMATODES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PARASITOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PARASITOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PARASITOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PREDATORY INSECTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PREDATORY INSECTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PREDATORY INSECTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CEREALS AND GRAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CEREALS AND GRAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CEREALS AND GRAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FRUITS AND VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FRUITS AND VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FRUITS AND VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY OILSEEDS AND PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY OILSEEDS AND PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY OILSEEDS AND PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY TURF AND ORNAMENTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY TURF AND ORNAMENTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY TURF AND ORNAMENTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY WETTABLE POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY WETTABLE POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY WETTABLE POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FOLIAR APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FOLIAR APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FOLIAR APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY POST-HARVEST APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY POST-HARVEST APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY POST-HARVEST APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GREENHOUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GREENHOUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GREENHOUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HOME AND GARDEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HOME AND GARDEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HOME AND GARDEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HORTICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HORTICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HORTICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 193. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 223. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)